+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Contraceptive Pills Market - Global Forecast 2026-2032- Product Image
Contraceptive Pills Market - Global Forecast 2026-2032- Product Image
New

Contraceptive Pills Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 198 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5716226
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The contraceptive pills market is experiencing significant transformation, with shifting expectations, innovation in formulations, and new routes to access exerting influence throughout the value chain. For senior decision-makers, maintaining visibility into evolving drivers and emerging risks is critical to sustain relevance and secure strategic advantage.

Market Snapshot: Contraceptive Pills Market Growth and Outlook

The global contraceptive pills market expanded from USD 22.12 billion in 2025 to USD 23.57 billion in 2026 and is projected to reach USD 34.79 billion by 2032, yielding a compound annual growth rate (CAGR) of 6.68%. Expansion is supported by continued clinical innovation, changing patient expectations, and key regulatory changes shaping access, differentiation, and product strategies. This robust growth highlights increased strategic opportunity but also intensifies the need for proactive market analysis.

Scope & Segmentation: Contraceptive Pills Market Landscape

  • Formulation Types: Includes combination options such as monophasic, biphasic, triphasic, and quadriphasic pills, as well as progestin-only pills, each catering to diverse hormone tolerance and medical requirements.
  • Packaging Options: Encompasses blister packs and strip packs, which play a role in drug protection, dosing compliance, and ease of pharmacy dispensing.
  • Dosing Cycles: Covers popular 21-day and 28-day regimens, along with extended-cycle alternatives, reflecting patients' lifestyle alignment and menstrual management preferences.
  • Pricing Tiers: Branded and generic contraceptive pills present varied market positions based on support, promotional focus, and access models.
  • Distribution Channels: Clinic, hospital, online, and retail pharmacies (both chain and independent) deliver products through different points of care and consumer engagement.
  • End-User Segments: Targets include adolescents, adults (by age cohorts), and mature adults, each presenting unique patterns of adherence, cost sensitivity, and care priorities.
  • Regional Coverage: Regions such as the Americas, Europe, Middle East & Africa, and Asia-Pacific each exhibit distinct regulatory, access, and manufacturing contexts.
  • Technology Integration: Advanced digital adherence tools and telemedicine platforms increasingly support patient engagement, adherence monitoring, and overall product tracking within the contraceptive pills market.

Key Takeaways for Senior Decision-Makers

  • Market priorities have shifted from solely maximizing efficacy to enhancing patient experience, emphasizing tolerability, convenience, and cost efficiency as differentiating features.
  • The surge of telehealth and online pharmacy solutions is reshaping prescription models, broadening market reach, and requiring revised engagement tactics for both payers and manufacturers.
  • Packaging innovation and sustainable practices are influencing supply chain models, cost structures, and brand image, particularly among consumer groups with environmental concerns.
  • Integrating regulatory awareness and cross-functional coordination is now essential, as shifts in over-the-counter availability and tariff regimes present both new risks and competitive possibilities.
  • Sustained competitive advantage increasingly depends on blending clinical results, digital engagement, robust regulatory strategies, and targeted channel partnerships adapted for local and regional markets.

Tariff Impact: Supply Chain and Sourcing Shifts

Recent tariff policies implemented in 2025 have escalated scrutiny on costs of inputs, customs procedures, and inventory planning within the contraceptive pills supply chain. Such policies have prompted manufacturers to adopt diversified sourcing, nearshoring investments, renegotiate supplier arrangements, and invest in operational efficiency to manage resulting cost increases and prevent disruptions. Collaborative actions between industry stakeholders and regulators, such as pursuing tariff exemptions for essential reproductive health products, emphasize the benefits of agile planning and open dialogue to overcome challenges posed by new trade structures.

Methodology & Data Sources

This report utilizes a mixed-methods approach, combining primary research with clinicians, procurement, and manufacturing experts; a structured secondary review of regulatory and clinical literature; and comprehensive supply chain analysis. Key insights reflect verified commercial realities and stakeholder perspectives relevant for senior decision-making.

Why This Report Matters

  • Enables executives to optimize product portfolios, supply strategies, and patient engagement within an evolving regulatory and access context.
  • Informs decision-making on sustainable packaging, investment in digital health, and locally relevant channels, supporting competitive positioning for the long term.
  • Delivers actionable intelligence to help organizations manage tariff-related risks, respond to market access transitions, and align with changing payer expectations.

Conclusion

Ongoing adaptation in operational structures and patient engagement, coupled with evidence-based channel strategies, is essential for maintaining market access and commercial strength. Strategic alignment across development, supply, and go-to-market functions supports sustained growth in a rapidly changing environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Contraceptive Pills Market, by Formulation
8.1. Combination Pill
8.1.1. Biphasic
8.1.2. Monophasic
8.1.2.1. Low Dose
8.1.2.2. Standard Dose
8.1.2.3. Ultra-Low Dose
8.1.3. Quadriphasic
8.1.4. Triphasic
8.2. Progestin-Only Pill
9. Contraceptive Pills Market, by Packaging
9.1. Blister Pack
9.2. Strip Pack
10. Contraceptive Pills Market, by Dosage Cycle
10.1. 21-Day Regimen
10.2. 28-Day Regimen
10.3. Extended Cycle
11. Contraceptive Pills Market, by End User
11.1. Adolescents
11.2. Adults
12. Contraceptive Pills Market, by Distribution Channel
12.1. Clinic Pharmacy
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
12.4.1. Chain Pharmacy
12.4.2. Independent Pharmacy
13. Contraceptive Pills Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Contraceptive Pills Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Contraceptive Pills Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Contraceptive Pills Market
17. China Contraceptive Pills Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AbbVie Inc.
18.6. Afaxys Pharma, LLC
18.7. Amneal Pharmaceuticals, Inc.
18.8. Apotex Inc.
18.9. Aurobindo Pharma Limited
18.10. Bayer AG
18.11. Bionpharma Inc.
18.12. Cipla Limited
18.13. Combe Incorporated
18.14. Dr. Reddy's Laboratories (DRL)
18.15. Gedeon Richter PLC
18.16. Glenmark Pharmaceuticals Limited
18.17. Johnson & Johnson Services, Inc.
18.18. Julie Product Inc.
18.19. Lupin Limited
18.20. Mankind Pharma Ltd.
18.21. McKesson Medical-Surgical Inc.
18.22. Merck & Co., Inc.
18.23. Perrigo Company plc
18.24. Pfizer Inc.
18.25. Piramal Enterprises Ltd.
18.26. Sun Pharmaceutical Industries Limited
18.27. Syzygy Healthcare Solutions, LLC
18.28. Teva Pharmaceuticals
18.29. Viatris Inc.
18.30. Xiromed, LLC
List of Figures
FIGURE 1. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BIPHASIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BIPHASIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BIPHASIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY LOW DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY LOW DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY LOW DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY STANDARD DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY STANDARD DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY STANDARD DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ULTRA-LOW DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ULTRA-LOW DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ULTRA-LOW DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY QUADRIPHASIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY QUADRIPHASIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY QUADRIPHASIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY TRIPHASIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY TRIPHASIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY TRIPHASIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILL, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACK, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY STRIP PACK, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY STRIP PACK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY STRIP PACK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 21-DAY REGIMEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 21-DAY REGIMEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 21-DAY REGIMEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 28-DAY REGIMEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 28-DAY REGIMEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 28-DAY REGIMEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY EXTENDED CYCLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY EXTENDED CYCLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY EXTENDED CYCLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ADOLESCENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ADOLESCENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CLINIC PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CLINIC PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CLINIC PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 113. EUROPE CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. EUROPE CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 115. EUROPE CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 116. EUROPE CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 117. EUROPE CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 118. EUROPE CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 119. EUROPE CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. EUROPE CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 121. EUROPE CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 131. AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 133. AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 134. AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 135. AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 136. AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 137. AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. ASEAN CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. ASEAN CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 152. ASEAN CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 153. ASEAN CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 154. ASEAN CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 155. ASEAN CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 156. ASEAN CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. ASEAN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. ASEAN CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 159. GCC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GCC CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 161. GCC CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 162. GCC CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 163. GCC CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 164. GCC CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 165. GCC CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. GCC CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 167. GCC CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 177. BRICS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. BRICS CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 179. BRICS CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 180. BRICS CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 181. BRICS CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 182. BRICS CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 183. BRICS CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. BRICS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. BRICS CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 186. G7 CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. G7 CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 188. G7 CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 189. G7 CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 190. G7 CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 191. G7 CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 192. G7 CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. G7 CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 194. G7 CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 195. NATO CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. NATO CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 197. NATO CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 198. NATO CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 199. NATO CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 200. NATO CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 201. NATO CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. NATO CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 203. NATO CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 206. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 207. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 208. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 209. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 210. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 211. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 213. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 214. CHINA CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 215. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 216. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2032 (USD MILLION)
TABLE 217. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2032 (USD MILLION)
TABLE 218. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 219. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2032 (USD MILLION)
TABLE 220. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 222. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Contraceptive Pills market report include:
  • AbbVie Inc.
  • Afaxys Pharma, LLC
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Bionpharma Inc.
  • Cipla Limited
  • Combe Incorporated
  • Dr. Reddy's Laboratories (DRL)
  • Gedeon Richter PLC
  • Glenmark Pharmaceuticals Limited
  • Johnson & Johnson Services, Inc.
  • Julie Product Inc.
  • Lupin Limited
  • Mankind Pharma Ltd.
  • McKesson Medical-Surgical Inc.
  • Merck & Co., Inc.
  • Perrigo Company plc
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Sun Pharmaceutical Industries Limited
  • Syzygy Healthcare Solutions, LLC
  • Teva Pharmaceuticals
  • Viatris Inc.
  • Xiromed, LLC

Table Information

Report AttributeDetails
No. of Pages198
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 23.57 Billion
Forecasted Market Value ( USD ) by 2032 $ 34.79 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Oral Contraceptive Pills Market - Global Forecast 2026-2032 - Product Image

Oral Contraceptive Pills Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Oral Contraceptive Pills Market Report 2025 - Product Image

Oral Contraceptive Pills Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Oral Contraceptive Pills Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Oral Contraceptive Pills Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Female Contraceptive Market - Global Forecast 2026-2032 - Product Image

Female Contraceptive Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Contraceptive Pills Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2020-2030F - Product Image

Contraceptive Pills Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2020-2030F

  • Report
  • 188 Pages
  • Global
From

About the Birth Control Pill Market

The Birth Control Pill is a form of contraception used by women to prevent pregnancy. It is a hormonal medication taken orally, usually once a day, and works by preventing ovulation and fertilization. It is one of the most popular forms of contraception in the world, and is widely used by women of all ages. The Birth Control Pill is an important part of Women's Health, as it provides women with the ability to control their reproductive health and plan their families. It is also used to treat a variety of medical conditions, such as endometriosis, polycystic ovary syndrome, and acne. The Birth Control Pill market is highly competitive, with many companies offering different types of pills. Some of the major players in the market include Bayer, Pfizer, Merck, and Teva Pharmaceuticals. Other companies include Mylan, Allergan, and Actavis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.